1.
Growth response of syndromic versus non-syndromic children born small for gestational age (SGA) to growth hormone therapy: a Belgian study.
2.
3.
4.
5.
6.
7.
The impact of reimbursement criteria on the appropriateness of 'statin' prescribing.